Gene · 7508
Papers3,752
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,752
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of xeroderma pigmentosum group C on the characteristics and regulatory mechanisms of lung cancer stem cells. | Int J Oncol | 2026 | 42695433 | PubTator, text mining | PubMed |
| TIP60 promotes chemoresistance by limiting intracellular platinum accumulation and enhancing removal of cisplatin-DNA adducts. | J Biol Chem | 2026 | 42463050 | PubTator, text mining | PubMed |
| Molecular mechanisms of DNA damage recognition and chromatin dynamics regulating mammalian nucleotide excision repair. | DNA Repair (Amst) | 2026 | 42419012 | PubTator, text mining | PubMed |
| DNA-repair and transcriptional defects drive hematologic malignancies in xeroderma pigmentosum group C patients: A new hypothesis. | DNA Repair (Amst) | 2026 | 42269320 | PubTator, text mining | PubMed |
| Canonical autophagy remains inactive in induced pluripotent stem cells and neuronal progenitor cells following DNA damage induced by BPDE or etoposide. | Sci Rep | 2026 | 42259994 | PubTator, text mining | PubMed |
| Vitamin D Supplementation Modulates Base Excision Repair (BER) Machinery in Systemic Sclerosis: A Prospective Longitudinal Study. | Biochem Genet | 2026 | 42258083 | PubTator, text mining | PubMed |
| XPC and global genome nucleotide excision repair are essential for telomere stability after UVC-induced DNA damage in human cells. | DNA Repair (Amst) | 2026 | 42247759 | PubTator, text mining | PubMed |
| microRNA miR-31-5p confers protection to melanin-deficient vitiligo keratinocytes against UV-B induced DNA damage by activating autophagy machinery. | Sci Rep | 2026 | 42230707 | PubTator, text mining | PubMed |
| [The Level of Methylation in the Promoter Regions of DNA Repair Genes in Chronically Exposed People]. | Mol Biol (Mosk) | 2026 | 42227125 | PubTator, text mining | PubMed |
| Higher Levels of BRCA1 Gene Methylation in Sporadic Breast Cancer Patients with a Lower Incidence of Recurrence. | Med Sci (Basel) | 2026 | 42201043 | PubTator, text mining | PubMed |
| A meta-analysis and expression profiling of DNA repair gene polymorphisms in leukemia. | Front Oncol | 2026 | 42109639 | PubTator, text mining | PubMed |
| High cancer-associated mutational burden in normal blood of xeroderma pigmentosum group C, but not groups A, D, or F. | Blood Neoplasia | 2026 | 41938744 | PubTator, text mining | PubMed |
| Th17 cells require the DNA repair sensor xeroderma pigmentosum complementation Group C to control oxidative DNA damage in a murine model. | Nat Commun | 2026 | 41922349 | PubTator, text mining | PubMed |
| Rare internal malignancies in xeroderma pigmentosum: A report of two cases from Tunisia and analysis of driver mutations. | Cancer Pathog Ther | 2026 | 41908666 | PubTator, text mining | PubMed |
| Ferroptosis in Glioblastoma and Neuroblastoma: Molecular Mechanisms and Novel Therapeutic Strategies. | Curr Issues Mol Biol | 2026 | 41899419 | PubTator, text mining | PubMed |
| Application and mechanistic research of novel therapeutic strategies in cisplatin-resistant small cell lung cancer. | Ann Med | 2026 | 41869709 | PubTator, text mining | PubMed |
| Association of XPC rs2228001, ESR2 rs1256030, and rs4986938 Gene Polymorphisms With Breast Cancer Risk in Bangladeshi Women: A Case-Control Study. | Clin Breast Cancer | 2026 | 41864051 | PubTator, text mining | PubMed |
| Contemporary management of treatment-related dermatologic toxicities in gynecologic cancers: a systematic review based on evidence from 2021 to 2025. | Front Med (Lausanne) | 2026 | 41797784 | PubTator, text mining | PubMed |
Computational identification of rare pathogenic genomic variants in esophageal cancer markers: Transcript-level analysis, sequence-based insights, and structural-functional impacts of non-synonymous SNPs. | Biochem Biophys Rep | 2026 | 41777455 | PubTator, text mining | PubMed |
| Structural pharmacogenomics of drug-associated SNPs in oral squamous cell carcinoma. | Front Genet | 2026 | 41757266 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7508/papers